Cargando…
P632: COMPARISON OF TREATMENT-EMERGENT ADVERSE EVENTS OF ACALABRUTINIB AND ZANUBRUTINIB IN CLINICAL TRIALS IN B-CELL MALIGNANCIES: A SYSTEMATIC REVIEW AND META-ANALYSIS
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428881/ http://dx.doi.org/10.1097/01.HS9.0000969432.47546.cf |
| _version_ | 1785090576473915392 |
|---|---|
| author | Hwang, Steven Wang, Jacqueline Tian, Zizhong Qi, Xinyue Jiang, Yi Zhang, Shijia Godby, Richard C. Parikh, Sameer Ding, Wei Hampel, Paul Munoz, Javier Paludo, Jonas Kenderian, Saad Muchtar, Eli Tsang, Mazie Hilal, Talal Leis, Jose Thanarajasingam, Gita Inwards, David Nowakowski, Grzegorz S. Ansell, Stephen Habermann, Thomas Witzig, Thomas Kay, Neil Zhou, Shouhao Wang, Yucai |
| author_facet | Hwang, Steven Wang, Jacqueline Tian, Zizhong Qi, Xinyue Jiang, Yi Zhang, Shijia Godby, Richard C. Parikh, Sameer Ding, Wei Hampel, Paul Munoz, Javier Paludo, Jonas Kenderian, Saad Muchtar, Eli Tsang, Mazie Hilal, Talal Leis, Jose Thanarajasingam, Gita Inwards, David Nowakowski, Grzegorz S. Ansell, Stephen Habermann, Thomas Witzig, Thomas Kay, Neil Zhou, Shouhao Wang, Yucai |
| author_sort | Hwang, Steven |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428881 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104288812023-08-17 P632: COMPARISON OF TREATMENT-EMERGENT ADVERSE EVENTS OF ACALABRUTINIB AND ZANUBRUTINIB IN CLINICAL TRIALS IN B-CELL MALIGNANCIES: A SYSTEMATIC REVIEW AND META-ANALYSIS Hwang, Steven Wang, Jacqueline Tian, Zizhong Qi, Xinyue Jiang, Yi Zhang, Shijia Godby, Richard C. Parikh, Sameer Ding, Wei Hampel, Paul Munoz, Javier Paludo, Jonas Kenderian, Saad Muchtar, Eli Tsang, Mazie Hilal, Talal Leis, Jose Thanarajasingam, Gita Inwards, David Nowakowski, Grzegorz S. Ansell, Stephen Habermann, Thomas Witzig, Thomas Kay, Neil Zhou, Shouhao Wang, Yucai Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428881/ http://dx.doi.org/10.1097/01.HS9.0000969432.47546.cf Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Hwang, Steven Wang, Jacqueline Tian, Zizhong Qi, Xinyue Jiang, Yi Zhang, Shijia Godby, Richard C. Parikh, Sameer Ding, Wei Hampel, Paul Munoz, Javier Paludo, Jonas Kenderian, Saad Muchtar, Eli Tsang, Mazie Hilal, Talal Leis, Jose Thanarajasingam, Gita Inwards, David Nowakowski, Grzegorz S. Ansell, Stephen Habermann, Thomas Witzig, Thomas Kay, Neil Zhou, Shouhao Wang, Yucai P632: COMPARISON OF TREATMENT-EMERGENT ADVERSE EVENTS OF ACALABRUTINIB AND ZANUBRUTINIB IN CLINICAL TRIALS IN B-CELL MALIGNANCIES: A SYSTEMATIC REVIEW AND META-ANALYSIS |
| title | P632: COMPARISON OF TREATMENT-EMERGENT ADVERSE EVENTS OF ACALABRUTINIB AND ZANUBRUTINIB IN CLINICAL TRIALS IN B-CELL MALIGNANCIES: A SYSTEMATIC REVIEW AND META-ANALYSIS |
| title_full | P632: COMPARISON OF TREATMENT-EMERGENT ADVERSE EVENTS OF ACALABRUTINIB AND ZANUBRUTINIB IN CLINICAL TRIALS IN B-CELL MALIGNANCIES: A SYSTEMATIC REVIEW AND META-ANALYSIS |
| title_fullStr | P632: COMPARISON OF TREATMENT-EMERGENT ADVERSE EVENTS OF ACALABRUTINIB AND ZANUBRUTINIB IN CLINICAL TRIALS IN B-CELL MALIGNANCIES: A SYSTEMATIC REVIEW AND META-ANALYSIS |
| title_full_unstemmed | P632: COMPARISON OF TREATMENT-EMERGENT ADVERSE EVENTS OF ACALABRUTINIB AND ZANUBRUTINIB IN CLINICAL TRIALS IN B-CELL MALIGNANCIES: A SYSTEMATIC REVIEW AND META-ANALYSIS |
| title_short | P632: COMPARISON OF TREATMENT-EMERGENT ADVERSE EVENTS OF ACALABRUTINIB AND ZANUBRUTINIB IN CLINICAL TRIALS IN B-CELL MALIGNANCIES: A SYSTEMATIC REVIEW AND META-ANALYSIS |
| title_sort | p632: comparison of treatment-emergent adverse events of acalabrutinib and zanubrutinib in clinical trials in b-cell malignancies: a systematic review and meta-analysis |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428881/ http://dx.doi.org/10.1097/01.HS9.0000969432.47546.cf |
| work_keys_str_mv | AT hwangsteven p632comparisonoftreatmentemergentadverseeventsofacalabrutinibandzanubrutinibinclinicaltrialsinbcellmalignanciesasystematicreviewandmetaanalysis AT wangjacqueline p632comparisonoftreatmentemergentadverseeventsofacalabrutinibandzanubrutinibinclinicaltrialsinbcellmalignanciesasystematicreviewandmetaanalysis AT tianzizhong p632comparisonoftreatmentemergentadverseeventsofacalabrutinibandzanubrutinibinclinicaltrialsinbcellmalignanciesasystematicreviewandmetaanalysis AT qixinyue p632comparisonoftreatmentemergentadverseeventsofacalabrutinibandzanubrutinibinclinicaltrialsinbcellmalignanciesasystematicreviewandmetaanalysis AT jiangyi p632comparisonoftreatmentemergentadverseeventsofacalabrutinibandzanubrutinibinclinicaltrialsinbcellmalignanciesasystematicreviewandmetaanalysis AT zhangshijia p632comparisonoftreatmentemergentadverseeventsofacalabrutinibandzanubrutinibinclinicaltrialsinbcellmalignanciesasystematicreviewandmetaanalysis AT godbyrichardc p632comparisonoftreatmentemergentadverseeventsofacalabrutinibandzanubrutinibinclinicaltrialsinbcellmalignanciesasystematicreviewandmetaanalysis AT parikhsameer p632comparisonoftreatmentemergentadverseeventsofacalabrutinibandzanubrutinibinclinicaltrialsinbcellmalignanciesasystematicreviewandmetaanalysis AT dingwei p632comparisonoftreatmentemergentadverseeventsofacalabrutinibandzanubrutinibinclinicaltrialsinbcellmalignanciesasystematicreviewandmetaanalysis AT hampelpaul p632comparisonoftreatmentemergentadverseeventsofacalabrutinibandzanubrutinibinclinicaltrialsinbcellmalignanciesasystematicreviewandmetaanalysis AT munozjavier p632comparisonoftreatmentemergentadverseeventsofacalabrutinibandzanubrutinibinclinicaltrialsinbcellmalignanciesasystematicreviewandmetaanalysis AT paludojonas p632comparisonoftreatmentemergentadverseeventsofacalabrutinibandzanubrutinibinclinicaltrialsinbcellmalignanciesasystematicreviewandmetaanalysis AT kenderiansaad p632comparisonoftreatmentemergentadverseeventsofacalabrutinibandzanubrutinibinclinicaltrialsinbcellmalignanciesasystematicreviewandmetaanalysis AT muchtareli p632comparisonoftreatmentemergentadverseeventsofacalabrutinibandzanubrutinibinclinicaltrialsinbcellmalignanciesasystematicreviewandmetaanalysis AT tsangmazie p632comparisonoftreatmentemergentadverseeventsofacalabrutinibandzanubrutinibinclinicaltrialsinbcellmalignanciesasystematicreviewandmetaanalysis AT hilaltalal p632comparisonoftreatmentemergentadverseeventsofacalabrutinibandzanubrutinibinclinicaltrialsinbcellmalignanciesasystematicreviewandmetaanalysis AT leisjose p632comparisonoftreatmentemergentadverseeventsofacalabrutinibandzanubrutinibinclinicaltrialsinbcellmalignanciesasystematicreviewandmetaanalysis AT thanarajasingamgita p632comparisonoftreatmentemergentadverseeventsofacalabrutinibandzanubrutinibinclinicaltrialsinbcellmalignanciesasystematicreviewandmetaanalysis AT inwardsdavid p632comparisonoftreatmentemergentadverseeventsofacalabrutinibandzanubrutinibinclinicaltrialsinbcellmalignanciesasystematicreviewandmetaanalysis AT nowakowskigrzegorzs p632comparisonoftreatmentemergentadverseeventsofacalabrutinibandzanubrutinibinclinicaltrialsinbcellmalignanciesasystematicreviewandmetaanalysis AT ansellstephen p632comparisonoftreatmentemergentadverseeventsofacalabrutinibandzanubrutinibinclinicaltrialsinbcellmalignanciesasystematicreviewandmetaanalysis AT habermannthomas p632comparisonoftreatmentemergentadverseeventsofacalabrutinibandzanubrutinibinclinicaltrialsinbcellmalignanciesasystematicreviewandmetaanalysis AT witzigthomas p632comparisonoftreatmentemergentadverseeventsofacalabrutinibandzanubrutinibinclinicaltrialsinbcellmalignanciesasystematicreviewandmetaanalysis AT kayneil p632comparisonoftreatmentemergentadverseeventsofacalabrutinibandzanubrutinibinclinicaltrialsinbcellmalignanciesasystematicreviewandmetaanalysis AT zhoushouhao p632comparisonoftreatmentemergentadverseeventsofacalabrutinibandzanubrutinibinclinicaltrialsinbcellmalignanciesasystematicreviewandmetaanalysis AT wangyucai p632comparisonoftreatmentemergentadverseeventsofacalabrutinibandzanubrutinibinclinicaltrialsinbcellmalignanciesasystematicreviewandmetaanalysis |